Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The seeds from Sipp Industries are already in cans:
The Hempire Strikes Back IPA
Labeling cans during today’s packaging run of Hempire Strykes Back IPA #BehindTheScenes #BreweryLife @TritonBrewing #HempBeer pic.twitter.com/dLRVqClfjh
— Athena Scholl (@Arieschura) September 12, 2018
Is the label also approved?
Beverage stocks hot now after coca cola news.
911 trades showing up!!!
Straight up!!!!!
Can we close at 6 bucks today?
That's a good one for a happy meal:
Cannacoke with a cannaburger.
Nice, MHBA and MHIPA selling global. Can you imagine?
Great!!! Bring that hemp beer to Europe, we are thirsty.
Dividend had been quadruppled in 2 years.
Thank you, very kind of you. I live in Ede, Holland. Although we produce hemp here, i couldn't find a tasty hemp beer. Would love to try it but they don't sell internationaly (yet).
I am sure that it can become a bestseller here.
Yes, i am ready for MHBA in cans and MHIPA in six-packs. Can Ted send them to the Octoberfest in Europe? I want to taste a REAL hemp beer.
CV Sciences (CVSI), a manufacturer and supplier of hemp-based CBD products, announced that its CBD Gold Extract, which includes all of PlusCBD Oil™ Gold Formula product line, has received self-affirmed Generally Recognized as Safe (GRAS) status in keeping with U.S. Food and Drug Administration (FDA) safety guidelines.
CV Sciences is the only hemp-based CBD company at present to receive this designation.
In a statement, CV Sciences CEO Joseph Dowling hailed the designation as a significant milestone and stated that GRAS self-affirmation would help broaden consumer access to the company’s products.
SIPP INDUSTRIES/SH (OTCMKTS:SIPC) has reported that it has joined hands with The Church Street Brewing Company. This partnership aims to co-create and manufacture Major Hemp Hipa, which is a new type of beer. The said beer will become the second hemp beer flavor to be produced by Siip Industries.
Siip Industries is an all round corporation that focuses on production and supply of consumer and commercial goods. It also has interests in the technology sector. The corporation is Major Hemp’s sole parent company.
The Church Street Brewing company which is based in a western suburb of Chicago, IL, Itasca is a craft brewery. It manufactures a variety of traditional and modest lagers as well as ales. The Brewery’s products constitute the old and the modern beer styles of European taste.
Both companies agree
Both Major Hemp and Church Street have reached a decision to produce the new Major Hemp HIPA as well as distribute it across the entire state of Illinois. The said beer will be distributed in various cans and kegs.
Both companies were involved in the testing and sampling of the new hemp beer. Thus, they both agreed that the beer which has an Indian Pale Ale (IPA) flavor would offer a unique and acceptable beer to the Chicago market.
The said Hemp IPA recipe is still in the development-stage however, it is expected to be complete in the coming week. According to the deal, Siip industries is the owner of the new beer’s recipe while Church Street will submit the recipe to the Alcohol and Tobacco Trade (TTB) for approval.
Both companies are expecting production to commence in late August. Meanwhile, Siip is already designing labels for Major Hemp HIPA.
Working with Sleeping Giant Brewing Company
The company is working alongside Sleeping Giant Brewing Company and TTB to have the final labels of Major Hemp Brown Ale approved. It plans to produce the beer in cans.
Siip Industries is working with a professional services firm to deal with all the regulatory compliance requirements. The services constitute, filing required licenses with the TTB, submitting Tradename applications, applying for Label Approval Certificate, and Formulating the Commercial Artwork for TTB compliance.
Siip Industries is set to benefit from the services of the firm, as it is experienced in the beverage and alcohol sector. Thus, this partnership will help the company to distribute Major Hemp Brown Ale across the nation.
And if we look closer at the date of the reviews of their products, we see that the amount of the reviews are accelerating. This is big, no fake, and our CEO will show it next qtr.
And the big part of their revenues is that this is all recurring revenues. People try it once and buy it again. Future looks great. The stock price will follow. Sooner or later.
Great to read the reviews of one of their top products:
https://www.thebetterhealthstore.com/cv-sciences-plus-cbd-oil-gold-15mg-60softgels
Short seller Citron promoting this company.
Almost 1/10 of the float traded today. Strong hands will lock the float up as its getting tighter.
Huh? Which toxic financing?
Management fully paid off all outstanding debt.
CVSI is debt free.
I buy some extra more CVSI shares before the next run up and before the float is sold out. Qtr 3 numbers will be even more spectacular. Management should give monthly sales numbers as an answer tot the BS.
Read it and locked my position.
Next week this will fly again.
Crushing the 3 month high!!
Rocket ship. Ready to take off!!!
9$ reached!!!!
Think the float must have been locked up by now.
I have a strong feeling that this is just the start.
Investors searching for bargains in the hemp sector will find VATE.
Great tot see how fast this goes, and do not forget, this market is still in it's infancy!!
Going up strong, again!!!
EmergingGrowth.com is bullish too, and so am i!!!
https://emerginggrowth.com/cv-sciences-otcqb-cvsi-this-hot-cbd-stock-is-a-buy-and-hold-despite-bumpy-ride-to-nasdaq/
"This profitability is an indicator that the company understands the industry dynamics, making it a top candidate for Wall Street investors looking for an entry point into the fast-growing CBD space."
Net Earnings increased 88.9% to $5.6 million compared to $3.0 million for the same period last year.
Meritage Reports Second Quarter 2018 Results; Strong Earnings GrowthPress Release | 07/17/2018
GRAND RAPIDS, Mich., July 17, 2018 (GLOBE NEWSWIRE) -- Meritage Hospitality Group Inc. (OTCQX:MHGU), one of the nation’s premier restaurant operators, today reported financial results for the second quarter ended July 1, 2018.
SECOND QUARTER HIGHLIGHTS
Sales increased 48.5% to $116.9 million from $78.7 million for the same period last year.
Earnings from Operations increased 64.6% to $8.9 million from $5.4 million for the same period last year.
Net Earnings increased 88.9% to $5.6 million compared to $3.0 million for the same period last year.
Consolidated EBITDA (a non-GAAP measure) increased 40.1% to $12.1 million compared to $8.6 million in 2017.
The Company acquired an additional 56 Wendy’s restaurants located in four states during the first six months of fiscal 2018.
“We experienced strong sales and earnings growth in the second quarter through the successful integration of 56 newly-acquired Wendy’s restaurants. The Company is forecasting continued strong earnings growth for the balance of the year, with contributions from newly built, renovated and acquired restaurants. We continue to focus on people development and customer satisfaction in our efforts to deliver long-term profitable growth,” stated Robert Schermer, Jr., the Company’s CEO.
The Company has committed significant capital resources to the Wendy’s brand initiatives, and is planning to complete a significant number of renovations and/or newly built restaurant locations this year. Same store sales in newly built and re-imaged restaurants continue to deliver strong results as guests are rewarding restaurants for the upgraded facilities and improved overall consumer experience.
Six-Month Highlights
Sales for the six months increased 53.9% to a record $216.6 million compared to sales of $140.7 million for the same period last year.
Earnings from Operations increased 48.5% to $13.1 million compared to $8.8 million last year.
Net Earnings increased 45.4% to $7.1 million compared to $4.9 million for the same period last year.
Consolidated EBITDA (a non-GAAP measure) increased 37.4% to $19.1 million compared to $13.9 million last year.
Meritage continues to distinguish itself as a leader and innovate in the quick service restaurant segment, striving for best in class results through a performance based culture committed to operational excellence, strategic acquisitions and real estate development.
Company 2018 Full-Year Financial Targets: Strong Growth Ahead
Sales growth of +40% to 50%
Incomes from Operations growth of +55% to 65%
New Earnings growth of +45% to 55%
EBITDA growth of +40% to 50%
Common stock dividend growth of +50% to 100%
About the Company
Meritage Hospitality Group is one of the nation’s premier restaurant operators, with 311 restaurants in operation located in Arkansas, Connecticut, Florida, Georgia, Indiana, Massachusetts, Michigan, Missouri, Mississippi, North Carolina, South Carolina, Ohio, Oklahoma, Tennessee, Texas and Virginia. Meritage is headquartered in Grand Rapids, Michigan, operating with a workforce of approximately 10,000 employees. The Company has approximately 6.2 million (basic) common shares outstanding. The Company’s public filings can be viewed at www.otcmarkets.com, under the stock symbol MHGU, or the Company’s website www.meritagehospitality.com.
SAFE HARBOR STATEMENT
Certain information in this news release, particularly information regarding future economic performance and finances, and plans, expectations and objectives of management, constitutes forward-looking statements. Factors set forth in our Safe Harbor Statement, in addition to other possible factors not listed, could affect the Company’s actual results and cause such results to differ materially from those expressed in forward-looking statements. Please review the Company’s Safe Harbor Statement at http://www.meritagehospitality.com.
CONTACT:
Robert E. Schermer, Jr., CEO
Meritage Hospitality Group Inc.
616-776-2600 ext. 1012
The 2nd quarter numbers will move this big.
Medico just integrated the sales of Elev8: https://blessedbeancoffee.com/
But this sales is for the 3rd qtr.
2nd quarter numbers coming close:
Elev8 Brands, Inc. Acquires L & P Cold Brew, LLC to enter $71 Billion Market
Company’s Financial Audit Should be Completed Within 30 Days
ORLANDO, FL -- June 26, 2018 -- InvestorsHub NewsWire -- Elev8 Brands, Inc. (OTC Pink: VATE), a holding company focused on the commercial development of hemp and CBD-based products including hemp coffee, tea, CBD salve, CBD Lotions and CBD Tinctures that target the health and wellness markets, is pleased to announce the acquisition of L&P Cold Brew, LLC from Blessed Bean Coffee, a Florida Limited Liability Company. The acquisition allows Elev8 Brands to enter the ready to go market, which according to Food Business News, the global sales of ready to go coffee and tea market in 2015 was $71.4 billion.
A lot of growth ahead!!!!!!:
https://blessedbeancoffee.com/
Hemp legalization is imminent, National distribution is imminent
https://twitter.com/WheresMajorHemp
Are the deals already made?
I think YES
Great to be in here, in the early stages of this hypergrowth beer stock.
With news we will fly.
Some old news but i read it again and become more bullish about this CEO:
Company Further Reduces Debt and Avoids Dilution to Stockholders
LAS VEGAS, April 04, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our" or "we") announced today that it has paid the April 2018 installment obligation under its March 1, 2017 Convertible Promissory Note (the "Note") in cash, thus avoiding the lender's conversion of this amount under the terms of the Note. The Company issued the Note on March 1, 2017 in the original principal amount of $770,000, which provided the Company the right to satisfy installment obligations in cash or by conversion of the installment amount into shares of our Common Stock at a price determined upon the trading price of our stock during the period immediately prior to conversion. On April 2, 2018, the Company made payment to the holder of the Note equal to $100,000 and the lender accepted this payment.
"As recently reported in our Form 10-K filed on March 29, 2018, we made three monthly $100,000 repayments on this Note during the first quarter of 2018. We are continuing this monthly repayment schedule with this most recent payment. Our financial position continues to be very strong and has well-positioned the Company to satisfy all remaining debt obligations under this Note in cash," said Joseph Dowling, CFO of CV Sciences. "By repaying this debt obligation in cash, we will be able to avoid further dilutive issuances of our stock to the lender."
After payment of the April 2018 installment, the amount remaining due under the Note is approximately $224,600. The Company will continue to utilize cash flow in a manner that puts the interest of stockholders first, both in terms of continued growth and managing dilution.
Now on tap in The Crafty Fox: Hemp Seed Brown Ale
from Major Hemp
http://craftyfox.beer/drinks-2/
Nice, i got in after reading their impressive first quarter 2018 financial results:
Q4 2017 and 2017 Full Year - Operating Highlights
Record Q1 2018 Sales of $8,071,000, an increase of 114% compared to Q1 2017
Record Q1 2018 Gross Profit of $5,562,000, an increase of 129% compared to Q1 2017
Record Q1 2018 GAAP Net Income of $619,000, an improvement of $4,404,000 when compared to Q1 2017
Record Q1 2018 Cash Flow from Operations of $1,654,000, an improvement of $1,628,000 when compared to Q1 2017
Record Q1 2018 Adjusted EBITDA of $1,822,000, an improvement of $2,012,000 when compared to Q1 2017
Increased Retail Channel Distribution to 1,771 Stores as of March 31, 2018, an increase of 14% compared to three months ago at December 31, 2017
Continued Progress in Drug Development Division including preclinical progress with CVSI-007, the Company’s patent pending synthetic-based cannabidiol, which will be co-administered with nicotine to provide treatment options for smokeless tobacco use and addiction, currently a multibillion market with no currently FDA-approved drugs available to help patients.
Warning on OTC website:
Warning! This company has posted limited financial disclosure through the OTC Disclosure & News Service or is late in their filing obligations with the SEC.